Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Hartford Financial Services G Pref | HIG-G | Nov 25, 2024 | 25.14 | +0.03 |
Hartford Financial Services Group | HIG | Nov 25, 2024 | 121.52 | +0.66 |
Hartford Multifactor Developed Markets (ex-US) ETF | RODM | Nov 25, 2024 | 29.51 | -0.03 |
Harvard Bioscience | HBIO | Nov 25, 2024 | 2.24 | -1.32 |
Hasbro | HAS | Nov 25, 2024 | 64.35 | +2.93 |
Haverty Furniture Companies | HVT-A | Nov 25, 2024 | 24.41 | +9.61 |
Haverty Furniture Companies | HVT | Nov 25, 2024 | 24.61 | +4.50 |
Hawaiian Electric Industries | HE | Nov 25, 2024 | 10.98 | +3.49 |
Hawkins | HWKN | Nov 25, 2024 | 135.47 | +4.18 |
Hawthorn Bancshares | HWBK | Nov 25, 2024 | 31.72 | +4.27 |
Haymaker Acquisition 4 | HYAC | Nov 25, 2024 | 10.73 | +0.09 |
Haynes International | HAYN | Nov 25, 2024 | 60.99 | 0.00 |
Hayward | HAYW | Nov 25, 2024 | 16.40 | +2.12 |
HBT Financial | HBT | Nov 25, 2024 | 24.76 | +1.89 |
HCA Healthcare | HCA | Nov 25, 2024 | 325.62 | +0.21 |
HCI Group | HCI | Nov 25, 2024 | 113.00 | +1.46 |
HCM II Acquisition | HOND | Nov 25, 2024 | 10.00 | 0.00 |
HCM II Acquisition | HONDU | Nov 25, 2024 | 10.10 | -0.69 |
HCW Biologics | HCWB | Nov 25, 2024 | 0.61 | -21.06 |
HDFC Bank ADR | HDB | Nov 25, 2024 | 66.91 | +3.74 |
Health Catalyst | HCAT | Nov 25, 2024 | 8.52 | +4.80 |
Healthcare AI Acquisition A | HAIA | Nov 25, 2024 | 11.43 | -0.61 |
Healthcare Alphadex First Trust | FXH | Nov 25, 2024 | 110.74 | +1.19 |
Healthcare Bull 3X Direxion | CURE | Nov 25, 2024 | 109.34 | +2.65 |
Healthcare ETF Vanguard | VHT | Nov 25, 2024 | 268.46 | +0.99 |
Healthcare Realty Trust | HR | Nov 25, 2024 | 17.58 | +1.62 |
Healthcare Select Sector SPDR | XLV | Nov 25, 2024 | 145.39 | +0.85 |
Healthcare Services Group | HCSG | Nov 25, 2024 | 11.93 | +2.14 |
Healthcare Triangle | HCTI | Nov 25, 2024 | 0.89 | -18.35 |
HealthEquity | HQY | Nov 25, 2024 | 103.76 | -0.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.